Clinical Outcomes of Penicillin‐Based Therapy Compared to Alternative Enterococcal Treatment in Patients With Vancomycin‐Susceptible Enterococcal Bloodstream Infections: A Monocentric Cohort Study
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2026 (1)
Abstract
The aim of this retrospective cohort study was to evaluate clinical outcomes of penicillin‐based therapies (ampicillin, ampicillin/sulbactam, or piperacillin/tazobactam) compared with alternative therapies (glycopeptides, linezolid, or daptomycin) in patients with vancomycin‐susceptible enterococcal bloodstream infections (BSIs). Adult patients with a positive blood culture (BC) for a vancomycin‐susceptible Enterococcus species were screened from January 2017 to December 2018. Patients who received adequate antibiotic therapy for at least 48 h were enrolled. The primary outcome, 30‐day mortality, was compared between patients receiving penicillin‐based and those receiving alternative therapies using the Fisher exact test. Secondary outcomes included 90‐day mortality, relapse BSI, length of hospital stay (LOS), and potential antibiotic‐related adverse events. To identify independent predictors of 30‐day mortality, multivariable logistic regression analysis was weighted for ampicillin susceptibility using propensity scores. Of the 150 patients screened, 127 (84.6%) were included in the final analysis. Among them, 36 (28.3%) developed a septic shock. Aminopenicillin‐susceptible Enterococcus species (mainly E. faecalis ) accounted for 59.1% of bacteremia cases. Sixty‐seven (52.1%) patients received a penicillin‐based regimen (monotherapy n = 48, combination n = 19), and 60 (47.2%) patients received an alternative regimen. Patients receiving penicillin‐based therapy exhibited a lower 30‐day mortality rate of 13.4% compared to 40% ( p = 0.001) in those receiving alternative treatments. The 90‐day mortality rates were reduced (13.4% versus 41.7%), and LOS was shorter (median 21 versus 35 days) for patients with penicillin‐based therapy. There was no significant difference in relapse BSI or potential adverse events between the groups ( p > 0.05). However, in the multivariable weighted regression model, only septic shock (aOR with 95% CI: 23.53 [1.66; 334.54]) was identified as an independent positive predictor of 30‐day mortality. In conclusion, penicillin‐based therapy was still an effective and safe treatment but was not associated with an improved survival in a weighted analysis of patients with enterococcal BSI.Keywords
This publication has 28 references indexed in Scilit:
- Predictors of mortality of enterococcal bacteraemia and the role of source control interventions; a retrospective cohort studyInfection, 2025
- Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2024
- Early treatment response to piperacillin/tazobactam in patients with bloodstream infections caused by non-ESBL ampicillin/sulbactam-resistant Escherichia coli: a binational cohort studyInfection, 2023
- Short-course versus long-course antibiotic treatment for uncomplicated vancomycin-resistant enterococcal bacteraemia: a retrospective multicentre cohort studyClinical Microbiology and Infection, 2022
- Clinical and microbiological characteristics of bloodstream infections caused by Enterococcus spp. within internal medicine wards: a two-year single-centre experienceInternal and Emergency Medicine, 2022
- How do I manage a patient with enterococcal bacteraemia?Clinical Microbiology and Infection, 2021
- Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort studyClinical Microbiology and Infection, 2020
- Incidence of virulence determinants in clinical Enterococcus faecalis and Enterococcus faecium isolates collected in BulgariaThe Brazilian Journal of Infectious Diseases, 2016
- Incidence, Risk Factors, and Outcomes for Enterococcus spp. Blood Stream Infections: A Population-Based StudyInternational Journal of Infectious Diseases, 2014
- Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia—a five-year retrospective reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009